ACMUI Membership

The membership of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) includes health care professionals from various disciplines. The ACMUI is composed of the following: a nuclear medicine physician; a nuclear cardiologist; a medical physicist in nuclear medicine unsealed byproduct material; a medical physicist in radiation therapy; a radiation safety officer; a nuclear pharmacist; two radiation oncologists; a patients' rights advocate; a Food and Drug Administration representative; an Agreement State representative; a health care administrator; and a diagnostic radiologist.

Membership in the ACMUI is gained through a formal nomination and selection process. To fill vacancies on the ACMUI, the U.S. Nuclear Regulatory Commission (NRC) publishes a notice in the Federal Register requesting nominations from interested parties. After receiving nominations, the NRC convenes a selection panel consisting of NRC staff and a non-NRC Federal employee. This non-NRC Federal employee is always a professional who specializes in the vacancy to be filled. The selection panel evaluates each nominee and sends a recommendation for appointment by the Director, Office of Nuclear Material Safety and Safeguards. The Director reviews the recommendation, consults with the Commission, and appoints the ACMUI member.

ACMUI members are appointed to four-year terms and, with approval from NRC, may elect to serve up to two consecutive terms, for a maximum term of eight years.

Members pictured from left to right, top to bottom: Dr. Vasken Dilsizian, Mr. Richard Green, Dr. Michael O'Hara, Dr. Ronald Ennis, Dr. John Suh, Ms. Megan Shober, Ms. Laura Weil, Dr. Pat Zanzonico, Dr. Philip Alderson, Dr. Christopher Palestro, Mr. Zoubir Ouhib, and Dr. Darlene Metter.
Members pictured from left to right, top to bottom: Dr. Vasken Dilsizian, Mr. Richard Green, Dr. Michael O'Hara, Dr. Ronald Ennis, Dr. John Suh, Ms. Megan Shober, Ms. Laura Weil, Dr. Pat Zanzonico, Dr. Philip Alderson, Dr. Christopher Palestro, Mr. Zoubir Ouhib, and Dr. Darlene Metter.


For additional information on ACMUI membership see the list of ACMUI Specialties and Functions and NUREG/BR-0309, "Serving on the Advisory Committee on the Medical Uses of Isotopes (ACMUI): A Member's Guide."

Select one of the following names for biographical information.

Members:

 

See Previous ACMUI members

Rebecca Allen

Rebecca Allen

Rebecca Allen serves as the healthcare administrator representative on the ACMUI.  Ms. Allen was appointed to the ACMUI in May 2021.

Ms. Allen earned her Bachelor of University Studies from Morehead State University in 1996, and her Master of Science in Radiologic Science-Administration from Midwestern State University in 2002. She has also earned an Executive Leadership for Healthcare Professionals certificate from Cornell University in 2011.

Ms. Allen currently serves as the Assistant Vice President for Operations at the University of Cincinnati (UC) Health – Medical Center in Cincinnati, Ohio and serves as the Enterprise Director of Radiology at UC Health. As Enterprise Director of Radiology at UC Health, she is responsible for the primary leadership of all radiology services, including oversight of costs, regulatory compliance, and accreditation. She serves as the Senior Management Representative of the Radiation Safety Committee at UC Health.

Ms. Allen is also a part of the Board of Directors with the Association of Medical Imaging Management (AHRA) and is responsible for setting curriculum and structure for radiology administrators nationwide. She holds a Certified Radiology Administrator certificate with AHRA and was selected as Leader of the Quarter at UC Health. She also holds a certificate as a UC Health Performance Improvement Leader. Ms. Allen has extensive experience in improving radiology departments at multiple healthcare institutions. She has been involved with uses of radiation in the healing arts since 1997 and has served in healthcare leadership through various roles at multiple institutions. Ms. Allen has clinical service line oversight experience in diagnostic imaging, interventional radiology and cardiology, radiation oncology, perioperative services, pharmacy, respiratory, and laboratory.

To top of page

Vasken Dilsizian, M.D.

photo of Vasken Dilsizian, M.D., Nuclear Cardiologist

Vasken Dilsizian, M.D., FACC, FAHA, serves as the nuclear cardiologist representative on the ACMUI. Dr. Dilsizian was appointed to the ACMUI in May 2014.

Dr. Dilsizian earned a Bachelor of Science and Master of Science Degrees in Chemical Engineering from Tufts University in Medford, Massachusetts, and a Medical Degree from Tufts University School of Medicine, in Boston, Massachusetts. Dr. Dilsizian is board certified by the American Board of Internal Medicine, the American Board of Cardiovascular Medicine, and the American Board of Nuclear Medicine.

Dr. Dilsizian was appointed as professor of radiology and medicine at the University of Maryland School of Medicine in 2001, and the Director of Cardiovascular Nuclear Medicine and Cardiac PET within the Department of Diagnostic Radiology and Nuclear Medicine at the University of Maryland Medical Center. Dr. Dilsizian was appointed as the Chief of the Nuclear Medicine Division within the Department of Diagnostic Radiology University of Maryland School of Medicine in 2007. Prior to this appointment, Dr. Dilsizian served as the Director of Nuclear Cardiology at the National Institutes of Health (NIH) from 1992-2001.

Dr. Dilsizian is active and serves (and has served) in leadership roles in various professional organizations including the American Society of Nuclear Cardiology (ASNC), the Society for Nuclear Medicine and Molecular Imaging (SNMMI), the American College of Cardiology (ACC), and the American Heart Association (AHA). He is a founding member of ASNC and served as the Chair for the ASNC 2014 Scientific Program Committee. He served as the President of the Cardiovascular Council of the SNMMI (2013-2014) and was awarded the 2014 Hermann Blumgart Award for his innumerable contributions to the science of nuclear cardiology. In 2016, he was bestowed as "Master" of American Society of Nuclear Cardiology (MASNC) for his contribution to the field of nuclear cardiology and for holding senior leadership positions within the Society. Dr. Dilsizian was elected as the incoming Vice President Elect of the SNMMI in June of 2017, which will lead to the Presidency of the Society in 2 years (2019-2020). He was also selected to serve as a member of the Board of Scientific Counselors of the Clinical Center of the National Institutes of Health for four-years (2018-2022). Dr. Dilsizian also has experience serving on an FDA Federal Advisory Committee (Cardiovascular and Renal Drugs Advisory Committee). Dr. Dilsizian has over 208 original, peer-reviewed manuscripts and invited editorials/articles, 10 books, and 43 book chapters.

To top of page

Ronald D. Ennis, M.D.

photo of Ronald D. Ennis, M.D., Radiation Oncologist

Ronald D. Ennis, M.D., serves as the brachytherapy radiation oncologist representative on the ACMUI. Dr. Ennis was appointed in March 2015.

Dr. Ennis received his Bachelor of Arts from Columbia University in New York, NY and his Medical Degree from Yale University School of Medicine in New Haven, CT. Dr. Ennis was board certified in radiation oncology by the American Board of Radiology (ABR) in 1995. He served as the Director for the Department of Radiation Oncology at St. Luke's Roosevelt Hospital Center and as Associate Director for the Continuum Cancer Centers of New York, Continuum Health Partners, both in New York, New NY, for eight years (2005-2013) prior to joining the faculty at the Icahn School of Medicine at Mount Sinai in New York, NY in 2014. Dr. Ennis was appointed as the Director for the Department of Radiation Oncology at Mount Sinai Roosevelt Hospital in New York, NY in January 2014 where he also serves as Chairman of the Quality Assurance and Safety Committee for the Radiation Oncology department.

Dr. Ennis is active in various professional organizations including the American Society for Therapeutic Radiology and Oncology (ASTRO), the Roentgen Society, and the American Board of Radiology (ABR). He currently serves as the Vice Chairman of ASTRO's Government Relations Committee, Government Relations Council. He is a member of the Editorial Board and Manuscript Reviewer of the Journal of Clinical Oncology and Manuscript Reviewer of Urology; Brachytherapy; and Cancer. Dr. Ennis has over 40 peer-reviewed publications and over 80 abstracts, meeting proceedings, letters, invited chapters and thesis publications.

Dr. Ennis is also actively involved in research on methods for treating prostate cancer by treating just the tumor versus the whole gland.

To top of page

Richard L. Green

Richard L. Green

Richard L. Green serves as the Nuclear Pharmacist representative on the ACMUI. He was appointed to the ACMUI in May 2018.

Mr. Green holds a Bachelor's degree in Pharmacy from the University of Arizona in Tucson, Arizona and has been an Authorized Nuclear Pharmacist since 1988. In 1992, Mr. Green received his board certification in nuclear pharmacy by the Board of Pharmacy Specialties (BPS). He was appointed to the position of Director of Radiopharmacy Practice at Cardinal Health Nuclear Pharmacy Services (hereafter referred to as Cardinal Health) in 2006. Prior to that, Mr. Green served as the Program Manager and Senior Manager of Pharmacy Practice at Cardinal Health in Dublin Ohio, as the Pharmacy Manager and Radiation Safety Officer at Syncor International Corporation in Las Vegas, Nevada and as a Staff Pharmacist and Radiation Safety Officer for Syncor International Corporation in Phoenix, Arizona. Mr. Green has taught radiopharmacy to pharmacists as part of several university affiliated ANP certificate programs for the past 27 years.

Mr. Green has served on the BPS Nuclear Pharmacy Specialty Council as a specialist member and as elected Chair. Mr. Green was named a Fellow of the American Pharmacist Association in 2018. In addition, he is an active member of the Society of Nuclear Medicine and Molecular Imaging, the American Pharmacist Association and the American Society of Health System Pharmacists. Lastly, Mr. Green has made numerous presentations, has had articles accepted for publication as well as five patents.

To top of page

Hossein Jadvar, M.D., Ph.D.

Hossein Jadvar, Nuclear Medicine Physician

Hossein Jadvar, M.D., serves as the nuclear medicine physician representative on the ACMUI. Dr. Jadvar was appointed to the ACMUI in October 2019.

Dr. Jadvar received his Bachelor’s degree in chemical engineering from Iowa State University, Ames; a Master’s in biomedical engineering from University of Wisconsin, Madison; a Master’s in computer engineering and a Doctorate in bioengineering, both from the University of Michigan, Ann Arbor; a Medical Degree from the University of Chicago Pritzker School of Medicine; a Master’s degree in Public Health from Harvard University; and an Executive Master’s in Business Administration from University of Southern California Marshall School of Business. He completed an internship in internal medicine at the University of California San Francisco, followed by a residency in diagnostic radiology and nuclear medicine at Stanford University, and a clinical fellowship in positron emission tomography (PET) with the Harvard Medical School Joint Program in Nuclear Medicine. Dr. Jadvar has also completed executive educational certificate programs in clinical effectiveness at Harvard Medical School, and in leadership at the University of Pennsylvania (Wharton).

Dr. Jadvar currently serves as a tenured Professor of Radiology, Urology, and Biomedical Engineering at the University of Southern California (USC), Los Angeles, California.  He is also a member of the USC Norris Comprehensive Cancer Center.

Dr. Jadvar has authored more than 140 peer-reviewed journal articles, published 4 books, 39 book chapters, 9 U.S. and European patents, numerous conference abstracts and full articles, and has had more than 200 invited speaker presentations and visiting professorships at national and international venues. He serves on the editorial boards for several peer-reviewed journals, namely, the Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging (Associate Editor), Radiology (Consultant to the Editor), American Journal of Roentgenology (Assistant Editor), and Clinical Nuclear Medicine (Deputy Editor). His research interests include applications of PET in clinical outcome research and in translational molecular imaging research with particular current interest in prostate cancer, theranostics, and targeted radionuclide therapy.

Dr. Jadvar is the past president and fellow of both the American College of Nuclear Medicine (ACNM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Dr. Jadvar was a Visiting Associate Scientist in Bioengineering at the California Institute of Technology (Caltech) and has been a National Institutes of Health (NIH) funded investigator. He currently serves on multiple NIH review panels (with one term as a chartered member for MEDI study section). Dr. Jadvar also serves on the Department of Defense Congressionally Directed Medical Research Programs-Prostate Cancer Research Program as well as the Imaging Technology and Informatics Review Panel of the Cancer Prevention Research Institute of Texas (CPRIT). Dr. Jadvar is a recipient of the SNMMI Mark Tetalman Young Investigator Award, the Western Regional SNMMI Distinguished Scientist Award, the Academy of Radiology and Biomedical Imaging Research Distinguished Investigator Award, the inaugural fellowship in the USC Center for Excellence in Research, the inaugural Prof. Ajit Padhy Award from the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH), the SNMMI PET Center of Excellence Peter E. Valk Memorial Award, and the Best Mentor Award from both USC and the ACNM.

To top of page

Josh Mailman

Josh Mailman serves as the Patients’ Rights Advocate representative on the ACMUI. Mr. Mailman was appointed to the ACMUI in July 2021.

Josh is an internationally recognized advocate for neuroendocrine tumor patients as well as an advocate for nuclear medicine, and molecular imaging. He is the inaugural chairman of the Society of Nuclear Medicine and Molecular Imaging’s Patient Advocacy Advisory Board, a member of the Education and Research Foundation for Nuclear Medicine and Molecular Imaging Board.

Mr. Mailman also serves as President of NorCal CarciNET Community, an organization established to help those with neuroendocrine tumors and carcinoid to share challenges and experiences, learn about prognosis and treatments, find information, and improve communications between the medical community, patients and caregivers. Additionally, he serves as a patient advocate for the National Cancer Institute’s Gastrointestinal Steering Committee, and American Society of Clinical Oncology’s Research Committee.

Mr. Mailman has an MBA from the Anderson School of Management at UCLA and has been a technology entrepreneur for more than 20 years.

To top of page

 

Melissa C. Martin

Melissa C. Martin

Melissa C. Martin serves as the nuclear medicine medical physicist representative on the ACMUI. She was appointed to the ACMUI in August 2018.

Ms. Martin holds a Bachelors of Science degree in Engineering Technology (Radiation and Nuclear) from Oklahoma State University and a Master's degree in Medical Physics from University of California, Los Angeles.  Ms. Martin is board certified by the American Board of Radiology in Radiological Physics and by the American Board of Medical Physics in Radiation Oncology Physics. 

She was appointed to her current position of Certified Medical Physicist and President at Therapy Physics, Inc., a medical physics consulting firm, in 1992. Prior to this appointment, Ms. Martin has served as the Assistant Radiological Physicist and Assistant Radiation Safety Officer (RSO) at the Hospital of the Good Samaritan in Los Angeles, CA; as the Radiological Physicist and RSO at Memorial Medical Center in Long Beach, CA; as Radiological Physicist at St. Joseph Hospital in Orange, CA; and as an adjunct professor at California State University in Long Beach, CA.

Ms. Martin has served in numerous leadership positions in medical professional organizations, including the AAPM (past President and Chairman of the Board), American College of Medical Physics (Chair), American College of Radiology (Chair of Government Relations Committee of Commission on Medical Physics), Conference of Radiation Control Program Directors (Chairman of AAPM Workshop at Annual Meetings), and the American Board of Radiology (Member of Part 2 Diagnostic Physics Committee and Oral Board Examiner for Diagnostic Imaging and Medical Nuclear Physics Exams).  Ms. Martin has also worked with the International Atomic Energy Agency, the California Radiological Society, the Radiological Society of North America and the Health Physics Society.  In addition, Ms. Martin has authored many peer-reviewed research articles and has given numerous presentations as an invited speaker.

To top of page

Darlene F. Metter, M.D.

Darlene F. Metter, M.D.

Darlene F. Metter, M.D., serves as the Diagnostic Radiologist representative on the ACMUI.  Dr. Metter was appointed to the ACMUI in June 2016 and Vice Chair of the ACMUI in March 2018.

Dr. Metter holds a Bachelor's degree from University of Hawaii in Honolulu, Hawaii and a Medical Degree from John A. Burns School of Medicine at the University of Hawaii in Honolulu, Hawaii.  Dr. Metter received triple board certifications in family medicine by the American Board of Family Medicine (1981), in diagnostic radiology by the American Board of Radiology (1992), and in nuclear medicine by the American Board of Nuclear Medicine (1993). 

Dr. Metter currently serves as a professor of diagnostic radiology and family and community medicine at the University of Texas Health Science Center in San Antonio, Texas and as the site director for the nuclear medicine residency program for the San Antonio Uniformed Services Health Education Consortium.  She was appointed to the position of adjunct professor and cross-appointed faculty at the University of Texas Health Science Center (UTHSCSA) in 2011 and as professor in the Department of Radiology at UTHSCHSA in 2009.  Prior to that, Dr. Metter served as staff radiologist at CHRISTUS Santa Rosa Hospital Medical Center and Metropolitan Hospital.  She also served as clinic radiologist at the Alamo Diagnostic Imaging Center, Advanced Medical Imaging, at North San Pedro Imaging.

Dr. Metter holds a gubernatorial appointment to the Texas Radiation Advisory Board (TRAB) and serves and has served, in leadership positions for numerous professional organizations.  These organizations include the following:  the American Board of Radiology (Chair of the Certifying and Maintenance of Certification Exam for Nuclear Radiology), the American College of Radiology (ACR) (current member of the ACR Council Steering Committee and was named ACR Fellow in 2007), the Society of Nuclear Medicine and Molecular Imaging (SNMMI)(President of the Academic Council, past President of the Southwest Chapter of SNMMI, and past Chair of the Nuclear Medicine Program Directors), and the Accreditation Council for Graduate Medical Education (ACGME) (Chair of the Nuclear Medicine Residency Review Committee and Vice-Chair of ACGME Council of Review Committees).

To top of page

Michael D. O'Hara, Ph.D.

Photo Not Available placeholder image

Michael D. O'Hara, Ph.D., has served as the Food and Drug Administration (FDA) representative on the ACMUI since November 2014.

Dr. O'Hara earned his bachelor's degree in biology from D'Youville College in Buffalo, a master's degree in Natural Sciences from the State University of New York at Buffalo and a doctorate of philosphy in Biological Sciences from Wayne State University in Detroit. He completed a postdoctoral fellowship in the laboratory of Experimental Radiation Oncology at Thomas Jefferson University in Philadelphia.

He remained as a faculty member at Thomas Jefferson University Medical College in the Department of Radiation Oncology. He lead research efforts investigating the impact of chemical agents that modify the thermal response of normal and malignant tissues during thermal/radiotherapy and investigated bone marrow transplantation as a method to treat osteogenesis imperfecta. Dr. O'Hara regularly taught an undergraduate course in "Health Physics and Radiation Biology", lectured medical residents and was a member of the Institutional Animal Care and Use Committee.

Dr. O'Hara moved to Cordis / a Johnson and Johnson company to manage the firm's radiation therapy efforts involving radioactive endovascular stents and catheter-based radiation sources. He was promoted to a Johnson and Johnson Research Fellow and continued to assist Cordis and other Johnson and Johnson companies with radiation-based therapies.

He joined the Food and Drug Administration in 2004 in the Division of Biology in the Office of Science and Engineering Laboratories within the Center for Devices and Radiological Health. His activities included research studies involving Relative Biological effectiveness of ionizing radiation and the thermal / radiotherapeutic response of human tumor cells. He also served as the chairman of the Animal Care and Use Committee and has served as a member of the CDRH Radiology Standards Committee, the CDRH Radiofrequency Working Group, the Interagency Radiofrequency Working group and the Health and Human Services Radiation Biodosimetry Working Group. Dr. O'Hara served the Office of Device Evaluation and the Office of In Vitro Diagnostics as an Acting Branch Chief and later an Acting Deputy Division Director. He currently serves the Office of In Vitro Diagnostics and Radiological health as one of the Deputy Division Directors of the Division of Radiological Health. This division is responsible for the pre-market evaluation, post-market medical device reporting and compliance for all radiation emitting medical devices.

To top of page

Zoubir Ouhib

Zoubir Ouhib

Zoubir Ouhib serves as the Therapy Medical Physicist representative on the ACMUI. Mr. Ouhib was appointed to the ACMUI in April 2018.

Mr. Ouhib holds a Master's degree in Medical Physics from the University of Cincinnati in Cincinnati, Ohio and another Master's degree in Nuclear Engineering from Georgia Institute of Technology in Atlanta, Georgia. Mr. Ouhib received his board certification in radiation therapy by the American Board of Radiology in 1992.

Mr. Ouhib was appointed to his current position as Chief Medical Physicist at the Lynn Cancer Institute of the Boca Raton Community Hospital in 1998. Prior to that, Mr. Ouhib served as Director of Medical Physics at Elliot Hospital in Manchester, New Hampshire and as Medical Physicist at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.

Mr. Ouhib serves and has served, in numerous leadership positions. These organizations include the following: the American Association of Physicists in Medicine (AAPM) (Vice Chair of the AAPM Task Groups BTSC, TG244, TG-236, TG182, TG253 and Working Group on Brachytherapy), the American Brachytherapy Society (ABS) (Past Chair of the ABS Physics Committee, Chair of the ABS Patient Safety Committee, Chair of the ABS Quality of Management of Brachytherapy School, and Chair of the ABS Dosimetry and Clinical Practice Aspects of Skin Brachytherapy Working Group), the American College of Radiology, the American Society of Therapeutic Radiology and Oncology (ASTRO), and the European Society for Radiology and Oncology.

To top of page

Megan L. Shober

Megan L. Shober

Megan L. Shober serves as the Agreement State Representative on the ACMUI. Ms. Shober was appointed to the ACMUI in April 2018.

Ms. Shober holds a Bachelor's degree in Geology from the College of Wooster, in Ohio, and a Master's degree in Geophysics from the University of Wisconsin-Madison.

Since 2003, Ms. Shober has been a Nuclear Engineer for the Wisconsin Division of Public Health in Madison, Wisconsin, where she is responsible for licensing and inspecting radioactive materials licensees and participating in emergency response activities. Ms. Shober has been the lead investigator for medical events involving manual brachytherapy, High Dose Rate remote afterloaders, leaking sources and iodine-131 fetal exposure. In addition, Ms. Shober is a regulatory expert on licensing domestic supplies of molybdenum-99.

Ms. Shober is active in various professional organizations including the Conference for Radiation Control Program Directors and the Organization of Agreement States (OAS), where she served on the Executive Board from 2013-2016. From 2012-2014, Ms. Shober served as a co-chair of the NRC-OAS 10 CFR 35.1000 working group for the ViewRay™ System for Radiation Therapy. Ms. Shober has given conference presentations on the ViewRay™ System for Radiation Therapy, 10 CFR Part 37, and licensing alpha-emitting radiopharmaceuticals.

To top of page

Harvey B. Wolkov, M.D.

Harvey B. Wolkov, M.D.

Harvey B. Wolkov, M.D. serves as the gamma stereotactic radiosurgery Radiation Oncologist representative on the ACMUI. He was appointed to the ACMUI in April 2019.

Dr. Wolkov earned his Bachelor's degree in Microbiology and Master’s degree in BioNuclear Physics from Purdue University in Lafayette, Indiana, and his Medical degree from the Medical College of Ohio, in Toledo, Ohio. He completed his internship at the University of California, San Francisco Medical Center, and his residency at Stanford University Hospital and served as Chief Resident. He was board certified by the American Board of Radiology in Therapeutic Radiology in 1983.

Following completion of his residency, he was appointed to his current position as Radiation Oncologist at the Sutter Radiation Oncology Center in Sacramento, CA. He previously served as the Director of the Radiation Oncology Division of Radiological Associates of Sacramento Medical Group, the Medical Director of the Radiation Oncology Center at the Sutter Cancer Center, and as an Associate Clinical Professor of Radiology, Surgery, and Radiation Oncology at the University of California, Davis, School of Medicine.

Dr. Wolkov is an active member in numerous professional societies. He previously held leadership positions in many of them including: the American College of Radiology (ACR) as Chairman of the Radiation Oncology Committee on Standards and Accreditation and as an ACR Councilor; the American College of Radiation Oncology (ACRO), serving on the Board of Chancellors and as Co-Chair of the Standards Committee; and the American Society for Radiation Oncology (ASTRO) as a former member of the Board of Directors, former member of the Ethics Committee, and former Vice Chair of the Outcomes Research Committee. Dr. Wolkov is the past President of the California Radiological Society, the Northern California Radiation Oncology Society, and the Council of Affiliated Regional Radiation Oncology Societies.

His primary research interests are brain tumors, gamma knife radiosurgery, and innovative radiation modalities. Dr. Wolkov co-developed the first intraoperative radiation therapy program in the community hospital setting, co-developed the Gamma Knife Center at Sutter Cancer Center, and established the first Leksell Gamma Knife® Icon™ unit in North America.

To top of page

Page Last Reviewed/Updated Monday, October 04, 2021